These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Use of lophenal in patients with malignant ovarian tumors].
    Author: Kotova DG, Razgovorova ZK.
    Journal: Vopr Onkol; 1976; 22(10):51-7. PubMed ID: 1014494.
    Abstract:
    The use of lophenal in complex treatment of 27 patients with malignant ovarian tumors has shown that the substance possesses a definite antitumor activity, manifested in gaining the clinical effect in 60.9% of patients with an average duration of remission lasting for 5.3 months. The toxic effect on hemopoiesis as well as the side effect of the substance were liquidated by pharmacological drugs. It is concluded that lophenal should be used along with other chemotherapeutic drugs for treatment of patients with malignant ovarian tumors.
    [Abstract] [Full Text] [Related] [New Search]